Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-26

Clinical Trial Update: Study of Memantine Augmentation in Severe Obsessive-Compulsive Disorder

View source ↗

Summary

A completed clinical trial evaluating memantine augmentation for severe obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obsessive-Compulsive Disorder | Status: COMPLETED